The 26th Congress of Dermatology and dermatology of China Association of Dermatology and dermatology of China Association of Dermatology and dermatology of Anhui Province was officially held in the morning of August, 2019 The First Affiliated Hospital of Anhui Medical University, Institute of Dermatology and dermatology of Fudan University and Fudan University are jointly organized by the dermatology Rehabilitation Committee of Chinese Association of rehabilitation medicine, Chinese society of Integrated Chinese and Western medicine, dermatology and dermatology branch of China Association for the promotion of international exchange of medical care Affiliated Huashan Hospital, international psoriasis Association (IPC), China Japan Friendship Hospital, Dermatology Research Institute of Anhui Medical University, Institute of Dermatology, Chinese Academy of Medical Sciences, Anhui Provincial dermatology and venereal disease specialist medical association, psoriatic friends mutual aid network, Anhui Feirui Dermatology Research Institute and Hainan Boao super hospital dermatology medical center are jointly organized, with more than 700 skin at home and abroad Experts and scholars, as well as a number of well-known enterprises and media attended the conference.

        The opening ceremony of the conference was presided over by Professor Zheng Min of the Second Affiliated Hospital of Zhejiang University Medical College. Professor Zhang Xuejun, chairman of the psoriasis professional committee of Dermatology and Venereology branch of Chinese Medical Association, director of Institute of Dermatology of Fudan University, director of international psoriasis Association, and chief physician of Dermatology of the first affiliated medical college of Anhui Medical University, Professor Zhang Xuejun first addressed all the leaders, experts and The delegates, enterprises and media friends expressed their warm welcome and pointed out that the third China psoriasis conference was held in Hefei on the occasion of the 16th World psoriasis day, in order to jointly build a beautiful blueprint for healthy China, promote the development of psoriasis prevention and treatment in China, and improve the quality of life of patients with psoriasis, the third China psoriasis Congress was held in Hefei, hoping to further promote the development of China's psoriasis prevention and treatment Promote the development of psoriasis prevention and treatment in China, popularize the health science education of psoriasis patients, benefit millions of psoriasis patients in China, and keep pace with the level of psoriasis diagnosis and treatment in the world.

        Professor Zheng Jie of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University made a speech, stressing that there may be more than 8 million psoriasis patients in China, and the diagnosis and treatment of psoriasis are gradually receiving extensive attention from people at all levels of society. Following the success of the previous two "China psoriasis Congress", this meeting was held to accelerate the standardized diagnosis and treatment of psoriasis in China and promote the development and progress of psoriasis prevention and treatment. It is believed that under the promotion of this psoriasis conference, it will further promote the rapid development of basic research and clinical prevention and treatment of psoriasis in China, enhance the care of people from all walks of life for psoriasis patients, and benefit millions of psoriasis patients in China.

        Professor He Li, from the Department of Dermatology, the First Affiliated Hospital of Kunming Medical University, said that psoriasis has been seriously harming the physical and mental health of people in China and the world, greatly reducing the quality of life of patients. At present, psoriasis has not yet entered the chronic disease management system, many drugs have not been included in the medical insurance, and there is still a long way to go for the future. I believe that through the academic exchange of this psoriasis conference and the public welfare activities of 100 famous doctors, it will play an important role in promoting the popularization of psoriasis health science education and psoriasis diagnosis and treatment in China, so as to improve the basic research and treatment of psoriasis in China Clinical diagnosis and treatment and standardized management have played an important role in promoting.

        In order to honor the experts and scholars who have made outstanding contributions in the field of psoriasis in China, the "Lifetime Achievement Award" and "tomorrow Star Award" were specially set up in this conference, which were awarded to Professor Liu Yufeng of Xijing Hospital of the Fourth Military Medical University, Professor Lu Chengzhi, vice president of Dalian Dermatology Hospital, Professor Chen Min, chief physician of Dermatology Hospital of Chinese Academy of Medical Sciences, and Chengdu City Professor Lu Yonghong, director of Dermatology Department of the second people's Hospital, was awarded the "star of tomorrow Award" by Professor Zhang Xuejun, Professor Zheng Jie and Professor Zheng Min respectively.

        In the prevention and treatment of psoriasis, a number of excellent diagnosis and treatment units have emerged. In order to further standardize the management of specialized psoriasis clinics and demonstration outpatient clinics, the psoriasis special committee assessed and selected the psoriasis special outpatient clinics and demonstration outpatient clinics licensed in 2017 and 2018. After assessment, 10 special disease demonstration clinics and 2 excellent special disease demonstration clinics were selected from more than 200 special disease outpatient units in China, and the awarding ceremony of award-winning outpatient units was held in this conference.

        After the opening ceremony, famous psoriasis experts at home and abroad reported the latest prevention and treatment experience of psoriasis, the global overview of psoriasis prevention and treatment, and psoriasis related scientific research achievements. The first half of the report was presided over by Professor Li Yuzhen of the Second Affiliated Hospital of Harbin Medical University, Professor Sun Liangdan of the First Affiliated Hospital of Anhui Medical University and Professor Wang Zaixing of the First Affiliated Hospital of Anhui Medical University. At the beginning of the report, Professor Zhang Xuejun shared with us "the past, present and future of dermatology research in China", and told the participants about the development process of dermatology in China, the status quo of Chinese dermatologists and the research results of dermatology. Professor Zhang believed that Chinese dermatologists still need to work hard in the future to further enhance the research of dermatology in China Influence in the world. Then Professor Zheng Jie brought us "the relevant factors and mechanisms of psoriasis occurrence and recurrence", and introduced in detail the role of cold, sleep deprivation and infection in the pathogenesis of psoriasis. Professor Richard Langley of Canada, director of international psoriasis Association, introduced "IL-23 / Th17 pathway in psoriasis" for us, and pointed out that the current basic research progress of psoriasis will further improve the level of diagnosis and treatment of psoriasis. Professor Las Iversen of Denmark, executive director of international psoriasis Association, also brought us the conference report "psoriasis going from an acute to a chronic disease", which clearly pointed out that early active treatment can shorten the course of psoriasis. Professor Zhang Jianzhong of Peking University People's hospital has focused on the innovative drug treatment of psoriasis, and thinks that they have brought a new revolution in the field of psoriasis treatment, and a series of new drugs need to be found by more medical workers. Professor He Li, the First Affiliated Hospital of Kunming Medical University, discussed the mechanism of skin barrier damage and repair from clinical and pathological perspectives.

        This conference cannot be held without the support of enterprises. The second half of the conference report is a special session of the satellite conference, which is jointly presided over by Professor Zhang Xuejun and Professor Zheng min. Professor Zhang Xibao, director of the Institute of Dermatology, Guangzhou Medical University, introduced the "evolution of biological agent therapy for psoriasis", which made the participants understand the history of psoriasis treatment and draw valuable experience from the development process of biological agent treatment of psoriasis. Professor jashin J. Wu, director of the international psoriasis Association and from the Irvine foundation for dermatology research and education, California, USA, brought "the new perspectives on psoriasis" by Novartis satellite, which interpreted psoriasis from a new perspective and made the delegates refreshing. Professor Shi Yuling, vice president of Shanghai Dermatology Hospital, shared the "common problems and solutions in the management of patients with psoriasis vulgaris" by Professor Shi Yuling, vice president of Shanghai Dermatology Hospital, which provided valuable experience for promoting the further promotion of clinical psoriasis patient management and diagnosis and treatment work by other diagnosis and treatment units.

        In the morning's academic conference, experts from basic research progress to specific treatment methods, from individual clinical programs and overall standardized guidelines, from traditional diagnostic methods to emerging drug research and development, provided a rare academic feast for the participants. The rich and colorful reports of the speakers were highly praised by the delegates. The atmosphere was warm and the applause was continuous. Everyone expressed their expectation for the report of the psoriasis conference in the afternoon.